Neurogastrx: $60M crossover round to advance de-risked GI assets
Emerging Company Profile: Funding, assist from Vivo to land Phase III-ready Daewoong asset readies biotech to build on its CEO’s Ironwood roots
Fresh funding and an assist from lead investor Vivo to bring in a Phase III-ready Daewoong asset sets Neurogastrx up to capitalize on its CEO’s Ironwood roots.
Aug 26, 2021 | 10:58 PM GMT
A June deal that came together through Vivo Capital brought a Phase III-ready asset into the hands of